BioLife Solutions, Inc. Lease, Cost
BioLife Solutions, Inc. (BLFS) reported Lease, Cost of $976.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-06
- BioLife Solutions, Inc. lease, cost for the quarter ending 2026-06-30 was $976.00K, a 12.44% increase year-over-year.
- BioLife Solutions, Inc. lease, cost for the quarter ending 2026-03-31 was $989.00K, a 7.73% increase year-over-year.
- BioLife Solutions, Inc. lease, cost for the quarter ending 2025-12-31 was $741.00K, a 13.74% decline year-over-year.
- BioLife Solutions, Inc. lease, cost for the quarter ending 2025-09-30 was $931.00K, a 3.52% decline year-over-year.
- BioLife Solutions, Inc. lease, cost for fiscal 2025 was $3.53M, a 14.03% increase from fiscal 2024.
- BioLife Solutions, Inc. lease, cost for fiscal 2024 was $3.09M, a 18.14% increase from fiscal 2023.
- BioLife Solutions, Inc. lease, cost for fiscal 2023 was $2.62M, a 4.05% increase from fiscal 2022.
- BioLife Solutions, Inc. lease, cost for fiscal 2022 was $2.52M, a 53.89% decline from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 9 month as first filed | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $976.00K 10-Q · filed 2026-08-06 | $1.97M 10-Q · filed 2026-08-06 | $2.71M derived: sum of 3 quarters · filed 2026-08-06 | $3.64M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $989.00K 10-Q · filed 2026-05-07 | $1.73M derived: sum of 2 quarters · filed 2026-05-07 | $2.66M derived: sum of 3 quarters · filed 2026-05-07 | $3.53M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $741.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.67M derived: sum of 2 quarters · filed 2026-02-26 | $2.54M derived: sum of 3 quarters · filed 2026-08-06 | $3.53M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $931.00K 10-Q · filed 2025-11-06 | $1.80M derived: sum of 2 quarters · filed 2026-08-06 | $2.79M 10-Q · filed 2025-11-06 | $3.58M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $868.00K 10-Q · filed 2026-08-06 | $903.00K 10-Q · filed 2025-08-07 | $1.79M 10-Q · filed 2026-08-06 | $1.86M 10-Q · filed 2025-08-07 | $2.65M derived: sum of 3 quarters · filed 2026-08-06 | $3.61M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $918.00K 10-Q · filed 2026-05-07 | $954.00K 10-Q · filed 2025-05-08 | $1.78M derived: sum of 2 quarters · filed 2026-05-07 | $2.74M derived: sum of 3 quarters · filed 2026-05-07 | $3.37M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $859.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.82M derived: sum of 2 quarters · filed 2026-02-26 | $2.45M derived: sum of 3 quarters · filed 2026-02-26 | $3.09M 10-K · filed 2026-02-26 | $3.16M 10-K · filed 2025-03-03 | |||
| 2024-09-30 | $965.00K 10-Q · filed 2025-11-06 | $1.97M 10-Q · filed 2024-11-12 | $1.59M derived: sum of 2 quarters · filed 2025-11-06 | $2.23M 10-Q · filed 2025-11-06 | $5.24M 10-Q · filed 2024-11-12 | $225.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $629.00K 10-Q · filed 2025-08-07 | $1.67M 10-Q · filed 2024-08-09 | $1.27M 10-Q · filed 2025-08-07 | $3.27M 10-Q · filed 2024-08-09 | -$740.00K derived: sum of 3 quarters · filed 2026-02-26 | $879.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $641.00K 10-Q · filed 2025-05-08 | $1.67M 10-Q · filed 2024-05-10 | -$1.37M derived: sum of 2 quarters · filed 2026-02-26 | $250.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.82M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$391.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.18M derived: sum of 3 quarters · filed 2026-02-26 | $2.62M 10-K · filed 2026-02-26 | $7.26M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $1.62M 10-Q · filed 2024-11-12 | $1.74M 10-Q · filed 2023-11-09 | $3.19M derived: sum of 2 quarters · filed 2024-11-12 | $4.63M 10-Q · filed 2024-11-12 | $4.99M 10-Q · filed 2023-11-09 | $2.08M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | $1.57M 10-Q · filed 2024-08-09 | $1.69M 10-Q · filed 2023-08-09 | $3.01M 10-Q · filed 2024-08-09 | $3.25M 10-Q · filed 2023-08-09 | $464.00K derived: sum of 3 quarters · filed 2025-03-03 | $2.16M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $1.56M 10-Q · filed 2024-05-10 | -$1.11M derived: sum of 2 quarters · filed 2025-03-03 | $587.00K derived: sum of 3 quarters · filed 2025-03-03 | $2.29M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | -$2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$971.00K derived: sum of 2 quarters · filed 2025-03-03 | $731.00K derived: sum of 3 quarters · filed 2025-03-03 | $2.52M 10-K · filed 2025-03-03 | $6.95M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $1.69M 10-Q · filed 2023-11-09 | $3.40M derived: sum of 2 quarters · filed 2023-11-09 | $5.18M 10-Q · filed 2023-11-09 | $7.00M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $1.70M 10-Q · filed 2023-08-09 | $3.38M 10-Q · filed 2023-08-09 | $5.31M derived: sum of 3 quarters · filed 2024-02-29 | $6.81M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $1.78M 10-Q · filed 2023-05-11 | $3.61M derived: sum of 2 quarters · filed 2024-02-29 | $5.11M derived: sum of 3 quarters · filed 2024-02-29 | $6.39M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.32M derived: sum of 2 quarters · filed 2024-02-29 | $4.61M derived: sum of 3 quarters · filed 2024-02-29 | $5.46M 10-K · filed 2024-02-29 | $5.29M 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $1.50M 10-Q · filed 2022-11-09 | $2.78M derived: sum of 2 quarters · filed 2022-11-09 | $3.63M 10-Q · filed 2022-11-09 | $4.29M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-06-30 | $1.29M 10-Q · filed 2022-08-09 | $2.10M 10-Q · filed 2022-08-09 | $2.80M derived: sum of 3 quarters · filed 2023-03-31 | $3.03M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-03-31 | $725.00K 10-Q · filed 2022-05-10 | $1.51M derived: sum of 2 quarters · filed 2023-03-31 | $1.74M derived: sum of 3 quarters · filed 2023-03-31 | $1.97M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2020-12-31 | $788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.02M derived: sum of 2 quarters · filed 2023-03-31 | $1.25M derived: sum of 3 quarters · filed 2023-03-31 | $1.47M 10-K · filed 2023-03-31 | ||||
| 2020-09-30 | $229.00K 10-Q · filed 2021-11-15 | $458.00K derived: sum of 2 quarters · filed 2021-11-15 | $685.00K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $229.00K 10-Q · filed 2021-08-16 | $456.00K 10-Q · filed 2021-08-16 | ||||||
| 2019-12-31 | $962.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |